Linard et al. surveyed a prospective cohort and reported that among APOE-ε4 carriers—characterised by the authors as having a high frequency of HSV1 reactivation—those positive for IgM or those who had high IgG levels, had an increased risk of AD. This evidence concerns the gene CD40LG and Alzheimer disease.